DEDICATED TO THE FULL RANGE OF
CELLULAR DRUG THERAPY SERVICES
Providing whole-process services based on accurate detection for each session of cellular drug therapy
Learn more
As announced by Center for Medical Device Evaluation(CMDE) of National Medical Products Administration (NMPA), BioSwan is CAR-T cellular therapy flow cytometry kit has successfully passed the application for special review of national Innovative Medical Devices. Which is the first clinical detection product for CAR-T cellular therapy that enters the innovative "green channel" in China.